Cargando…
Stafiba: A STAT5‐Selective Small‐Molecule Inhibitor
The transcription factors STAT5a and STAT5b are constitutively active in many human tumors. Combined inhibition of both STAT5 proteins is a valuable approach with promising applications in tumor biology. We recently reported resorcinol bisphosphate as a moderately active inhibitor of the protein‐pro...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099813/ https://www.ncbi.nlm.nih.gov/pubmed/36300584 http://dx.doi.org/10.1002/cbic.202200553 |